Peregrine Pharmaceuticals, Inc. - Investor Relations

Investor Relations

Peregrine Pharmaceuticals, Inc.	Investor Relations/Corporate Communications
14282 Franklin Avenue, Tustin, CA 92780 Phone: 714-508-6000 Fax: 714-838-5817 info@peregrineinc.com	Amy Figueroa Tel: 800-987-8256 afigueroa@peregrineinc.com

Recent Press Releases

Sep 2, 2010
Peregrine to Report First Quarter Fiscal Year 2011 Financial Results After Market on September 9, 2010

Jul 14, 2010
Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2010 Financial Results

View all releases »

Upcoming Events

Sep 9, 2010 at 1:30 PM PT
First Quarter Fiscal Year 2011 Financial Results Conference Call

Sep 10, 2010 at 9:50 AM CET
10th International Symposium: Biological Therapy of Cancer: from Disease to Targeted Therapy

View all events & presentations »

Transfer Agent

Integrity Stock Transfer
3265 E. Warm Spring Rd.
Las Vegas, NV 89120
Telephone: (702) 317-7757
Toll Free: (877) 317-7757
Fax: (702) 796-5650
Email: stock@integritynevada.net

Stock Information

NASDAQ:PPHM
$1.46 - 0.01

Sep 3, 2010
4:00 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools